Due to their dura-based anatomical position, absence of the blood-brain barrier, and suppressed immunological milieu caused by high PD-L1 expression—linked to poor prognosis—meningiomas are more likely to experience tumor recurrence or progression (33, 34). Here, CD274 is linked to neoplasm.